Predict your next investment

Venture Capital
FINANCE | Investment Firms & Funds
thynkcapital.com

See what CB Insights has to offer

Investments

15

About Thynk Capital

Thynk Capital possesses a historical investment performance in the top 1% of venture capital. Focused on investments in early-stage pharma and biotech companies focused on extending HealthSpan and major diseases of Aging including Alzheimer's, Dementia, Kidney Disease, Cancer, Cardiovascular, Diabetes, Frailty, and Rare Disease which affect over 25% of the population and growing at 10%/year.

Thynk Capital Headquarter Location

2620 South Maryland Parkway #844-14

Las Vegas, Nevada, 89158,

United States

858-699-6256

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Thynk Capital News

Thynk Capital Investments

15 Investments

Thynk Capital has made 15 investments. Their latest investment was in Viscient Biosciences as part of their Seed VC on May 5, 2019.

CBI Logo

Thynk Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/30/2019

Seed VC

Viscient Biosciences

Yes

1

5/7/2019

Seed VC

Repair Biotechnologies

$2.15M

Yes

6

12/13/2017

Convertible Note

Theragene Pharmaceuticals

Yes

11/2/2017

Series A

Subscribe to see more

$99M

Subscribe to see more

10

9/25/2017

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/30/2019

5/7/2019

12/13/2017

11/2/2017

9/25/2017

Round

Seed VC

Seed VC

Convertible Note

Series A

Seed VC

Company

Viscient Biosciences

Repair Biotechnologies

Theragene Pharmaceuticals

Subscribe to see more

Subscribe to see more

Amount

$2.15M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

6

10

10

Thynk Capital Team

1 Team Member

Thynk Capital has 1 team member, including current Founder, Jim Plante.

Name

Work History

Title

Status

Jim Plante

Founder

Current

Name

Jim Plante

Work History

Title

Founder

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.